关于治疗最小婴儿的新兴共识
过去三十年来,专业学会、生物伦理委员会和新生儿重症监护病房父母普遍认同极早产儿维持生命治疗决策应基于临床医生与父母的共同决策(SDM)。然而证据显示SDM并非总被实践,实际研究中存在大量实践差异,似乎不大可能反映个体化决策。本文分析这种差异的来源,认为当前SDM框架基于结局稳定、客观、明确且沟通清晰的过于简单化假设;实际上生存和神经发育损害的预后数据深深依赖于治疗实践、产前管理、机构文化和报告惯例。作者提出更动态的SDM模型,承认情感复杂性、预后清晰度不断演变以及随时间迭代决策的需要,强调个体化评估、适当时试验性治疗以及基于信任、同理心和对变化临床现实回应的纵向对话。
要点
- 专业学会、生物伦理委员会和NICU父母已形成广泛共识:极早产儿维持生命治疗决策应基于临床医生与父母的共同决策(SDM)。
- 证据显示SDM并非总被实践,实际研究中存在大量实践差异,似乎不大可能反映个体化决策。
- 当前SDM框架基于结局稳定、客观、明确且沟通清晰的过于简单化假设;预后数据深深依赖于治疗实践、产前管理、机构文化和报告惯例。
- 作者提出更动态的SDM模型,承认情感复杂性、预后清晰度不断演变以及随时间迭代决策的需要。
- 该模型不将决策集中于胎龄等单一变量,而强调个体化评估、适当时试验性治疗以及基于信任、同理心和对变化临床现实回应的纵向对话。
适用人群与场景
- 极早产儿(最小婴儿)的维持生命治疗决策场景,涉及临床医生与父母。
处置流程与药物剂量
- 作者提出更动态的SDM模型,承认情感复杂性、预后清晰度不断演变以及随时间迭代决策的需要。
- 该模型不将决策集中于胎龄等单一变量,而强调个体化评估、适当时试验性治疗以及基于信任、同理心和对变化临床现实回应的纵向对话。
研究设计与关键结果
- 过去三十年来,专业学会、生物伦理委员会和NICU父母已形成广泛共识:极早产儿维持生命治疗决策应基于临床医生与父母的共同决策(SDM)。
- 证据显示SDM并非总被实践,实际研究中存在大量实践差异,似乎不大可能反映个体化决策。
- 当前SDM框架基于结局稳定、客观、明确且沟通清晰的过于简单化假设;实际上生存和神经发育损害的预后数据深深依赖于治疗实践、产前管理、机构文化和报告惯例。
- 这些模糊性使咨询复杂化、掩盖价值负载的判断并导致临床医生的道德困扰。
- 父母偏好异质,且往往反映与卫生专业人员不同的对残疾的态度。
证据类型、等级与局限
- 证据类型:综述/专家意见。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,临床医生与父母应带着谦逊、对痛苦的关注以及对每个婴儿和家庭最有利的共同承诺来应对持续的不确定性。
- 作者提出更动态的SDM模型,强调个体化评估、适当时试验性治疗以及基于信任、同理心和对变化临床现实回应的纵向对话,而非将决策集中于胎龄等单一变量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Over the past three decades, a broad consensus has emerged that decisions about life-sustaining treatment for extremely premature infants should be grounded in shared decision-making (SDM) between clinicians and parents. This consensus is endorsed by professional societies, bioethics commissions, and parents of babies in the neonatal intensive care unit. Despite this robust consensus, there is evidence that SDM is not always practiced. The evidence comes from observations of actual studies in which there is substantial practice variation that seems unlikely to reflect individualized decisions. In this paper, I examine the sources of that variation and argue that current SDM frameworks rest on an overly simplistic assumption that outcomes are stable, objective, unambiguous, and communicated clearly. In reality, prognostic data for survival and neurodevelopmental impairment are deeply contingent on treatment practices, prenatal management, institutional culture, and reporting conventions. These ambiguities complicate counseling, obscure value-laden judgments, and contribute to moral distress among clinicians. Moreover, parental preferences are heterogeneous and often reflect attitudes about disabilities that are different from the attitudes of health professionals. I propose a more dynamic model of SDM that acknowledges emotional complexity, evolving prognostic clarity, and the need for iterative decision-making over time. Rather than centering decisions on a single variable such as gestational age, this approach emphasizes individualized assessment, a trial of therapy when appropriate, and longitudinal conversations grounded in trust, empathy, and responsiveness to changing clinical realities. As neonatology continues to push the boundaries of viability-and as emerging technologies reshape the therapeutic landscape-ethical deliberation must keep pace. Clinicians and parents alike must navigate persistent uncertainty with humility, attentiveness to suffering, and a shared commitment to doing what is best for each infant and family.
参考来源
- Lantos JD. An emerging consensus about treatment of the tiniest babies. Semin Fetal Neonatal Med. 2026. PMID: 41986180. doi:10.1016/j.siny.2026.101712
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。